Characterisation of the European seal morbillivirus.

The ELISA test originally developed for the detection of serum antibodies to rinderpest virus has been shown to detect cross-reacting antibodies in sera of diseased common and grey seals. Analysis of sera collected from various seal populations is in progress to establish the correlation between different morbillivirus neutralisation tests, ELISA tests and the disease status of the animals. RNA purified from post-mortem tissues removed from diseased seals has been analysed by hybridisation with cloned cDNAs made to various genes of canine distemper, peste des petits ruminants, rinderpest and measles viruses. This study has confirmed the presence of RNA sequences characteristic of a morbillivirus, but shown that the virus is not identical with any known morbillivirus. Work is in progress to determine the nucleotide sequences of clones carrying inserts homologous to morbillivirus genes isolated from cDNA made on a template of infected seal tissue RNA.
AuthorsC J Bostock, T Barrett, J R Crowther
JournalVeterinary microbiology (Vet Microbiol) Vol. 23 Issue 1-4 Pg. 351-60 (Jun 1990) ISSN: 0378-1135 [Print] NETHERLANDS
PMID2402877 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • DNA Probes
  • Immune Sera
  • RNA, Viral
  • Animals
  • Antibodies, Viral (analysis, immunology)
  • Cross Reactions
  • DNA Probes
  • Enzyme-Linked Immunosorbent Assay
  • Europe
  • Immune Sera (immunology)
  • Nucleic Acid Hybridization
  • Paramyxoviridae (classification, genetics, immunology)
  • Pinnipedia
  • Precipitin Tests
  • RNA, Viral (analysis)
  • Respirovirus Infections (microbiology, veterinary)
  • Seals, Earless
  • Sequence Homology, Nucleic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: